During the past decade, Ospedale San Bortolo conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 11 clinical trials were completed, i.e. on average, 23.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 8 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale San Bortolo" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 18 trials, followed by "Fadoi Foundation, Italy" with 4 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Abbott Medical Devices" with 4 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale San Bortolo" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Niguarda Hospital" with 2 trials as a collaborator, "Ospedali Riuniti Ancona" with 2 trials as a collaborator, "A.O. Ospedale Papa Giovanni XXIII" with 1 trials as a collaborator and "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator. Other collaborators include 127 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale San Bortolo" are "Leukemia" (4 trials), "Acute Promyelocytic Leukemia" (3 trials), "Chronic Lymphocytic Leukemia" (3 trials), "Chronic Myeloid Leukemia" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Ospedale San Bortolo" in a lesser frequency.

Most popular intervention types in "Ospedale San Bortolo" are "Drug" (59 trials), "Device" (12 trials), "Biological" (8 trials), "Procedure" (8 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "cisplatin" (5 trials), "adjuvant therapy" (4 trials), "Cisplatin" (3 trials) and "Etrasimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Bortolo" are 83 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale San Bortolo". undefined are not yet recruiting, 16 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Ospedale San Bortolo, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Bortolo, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 10 trials that are defined as “Not Applicable".